Powder extensively hydrolysed formula (0913101) vs Pdr disc/non ACBS protein SfI metabolic condition (0913442)
Powder extensively hydrolysed formula (0913101) was dispensed 38,771.0× as often as Pdr disc/non ACBS protein SfI metabolic condition (0913442) in May 2026 — 38,771 items versus 1 in England.
Powder extensively hydrolysed formula (0913101) · May 2026
NHSBSA Prescription Cost Analysis
Pdr disc/non ACBS protein SfI metabolic condition (0913442) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913442): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Pdr disc/non ACBS protein SfI metabolic condition (0913442)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Pdr disc/non ACBS protein SfI metabolic condition (0913442) |
|---|---|---|
| Items, May 2026 | 38,771 | 1 |
| Items, last 12 months | 486,570 | 16 |
| Net ingredient cost, May 2026 | £2,918,919 | £604 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Pdr disc/non ACBS protein SfI metabolic condition (0913442).